Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 7—July 2020
Research Letter

Human Case of Severe Fever with Thrombocytopenia Syndrome Virus Infection, Taiwan, 2019

Shih-Huan Peng1, Su-Lin Yang1, Shih-En Tang, Tzy-Chen Wang, Tung-Chien Hsu, Chien-Ling Su, Meng-Yu Chen, Masayuki Shimojima, Tomoki Yoshikawa, and Pei-Yun ShuComments to Author 
Author affiliations: Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan (S.-H. Peng, S.-L. Yang, T.-C. Wang, T.-C. Hsu, C.-L. Su, M.-Y. Chen, P.-Y. Shu); Tri-Service General Hospital, Taipei (S.-E. Tang); National Defense Medical Center, Taipei (S.-E. Tang); Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei (S.-E. Tang); National Institute of Infectious Diseases, Tokyo, Japan (M. Shimojima, T. Yoshikawa)

Main Article

Table

Laboratory findings of patient with severe fever with thrombocytopenia syndrome virus infection, Taiwan, 2019.

Laboratory finding Patient value Reference range
Leukocytes, cells/μL 1.550 × 103 3.9–10.6 × 103
Erythrocytes, cells/μL 5.550 × 106 3.9–5.4 × 106
Hemoglobin, g/dL 16.0 12–16
Platelets/μL 41 × 103 150–400 × 103
% Neutrophils 68.4 42–74
% Lymphocytes 29.7 25–56
Aspartate transaminase, U/L 1,326 0–37
Alanine transaminase, U/L 569 0–40
Creatinine kinase, U/L 1,310 56–224
Creatinine, mg/dL 1.7 0.44–1.03
C-reactive protein, mg/L 7.8 <5
Total bilirubin, mg/dL 1.7 0.2–1.2
Glucose, mg/dL 250 70–100
Prothrombin time, s 14.4 6.6–11.6
Activated partial thromboplastin time, s 63.4 23.9–34.9

Main Article

1These first authors contributed equally to this article.

Page created: March 20, 2020
Page updated: June 18, 2020
Page reviewed: June 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external